US › Healthcare

Electrocore LLC (ECOR)

US · Healthcare · Medical Devices

$6.23+2.30%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$9.6M
Revenue YoY
+42.6%
Net profit
$-5.3M
Profit YoY
-36.7%
EPS
$-0.59
EPS estimate
$-0.61
Net margin
-55.0%

EPS came in at -0.59 against a street estimate of -0.61 — a beat of 3.3%.

Key statistics

Market cap
$54.9M
Forward P/E
384.6
P/B
34.89
Book value
$-0.70
EPS (TTM)
$-1.77
52-week high
$10.49
52-week low
$4.16
50-day MA
$7.80
200-day MA
$6.37
Beta
0.89

Analyst view

Analysts rate Electrocore LLC a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $19.57.

Shareholding

Insiders
32.40%
Institutions
8.44%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC2.44%
Balyasny Asset Management LLC1.40%
Geode Capital Management, LLC0.94%
JAFFETILCHIN INVESTMENT PARTNERS, LLC0.70%
Sontag Advisory LLC0.57%
International Assets Investment Management, LLC0.56%
Renaissance Technologies Corp0.54%
Vanguard Fiduciary Trust Co0.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Electrocore LLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.